Health Catalyst (NASDAQ:HCAT) Earns Outperform Rating from Analysts at Evercore ISI

Evercore ISI started coverage on shares of Health Catalyst (NASDAQ:HCAT) in a research report released on Monday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $50.00 target price on the stock.

NASDAQ HCAT opened at $43.66 on Monday. Health Catalyst has a 12 month low of $36.29 and a 12 month high of $49.85.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.

Further Reading: Green Investing

Analyst Recommendations for Health Catalyst (NASDAQ:HCAT)

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.